Myriad Genetics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MYGN and other ETFs, options, and stocks.

About MYGN

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. It operates through the Diagnostics and Other segments. 

CEO
Paul J. Diaz
CEOPaul J. Diaz
Employees
2,400
Employees2,400
Headquarters
Salt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded
1991
Founded1991
Employees
2,400
Employees2,400

MYGN Key Statistics

Market cap
1.59B
Market cap1.59B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
558.53K
Average volume558.53K
High today
$19.89
High today$19.89
Low today
$19.45
Low today$19.45
Open price
$19.69
Open price$19.69
Volume
110.90K
Volume110.90K
52 Week high
$28.45
52 Week high$28.45
52 Week low
$15.38
52 Week low$15.38

Analyst ratings

56%

of 9 ratings
Buy
0%
Hold
55.6%
Sell
44.4%

MYGN Earnings

-$0.19
-$0.09
$0.02
$0.12
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 23, Pre-Market
ActualExpected Feb 23, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.